Table 3.
Model 1: Joint effects of low 25(OH)D (yes vs. no) and high IL-6 (yes vs. no) | Model 2: Joint effects of low IGF-1 (yes vs. no) and high IL-6 (yes vs. no) | ||||
---|---|---|---|---|---|
Group | OR (95% CI) | p | Group | OR (95% CI) | p |
Yes, Yes | 1.63 (1.15, 2.32) | .006 | Yes, Yes | 1.65 (1.19, 2.29) | .003 |
No, Yes | 1.12 (0.80, 1.56) | .50 | No, Yes | 1.07 (0.75, 1.53) | .72 |
Yes, No | 0.89 (0.60, 1.30) | .54 | Yes, No | 0.91 (0.65, 1.27) | .57 |
No, No | Reference group | No, No | Reference group | ||
Follow-upf | Follow-upf | ||||
3-year | 1.59 (1.20, 2.12) | .001 | 3-year | 1.51 (1.18, 1.93) | .001 |
6-year | 1.32 (0.99, 1.77) | .06 | 6-year | 1.28 (0.97, 1.69) | .08 |
Note: CI = Confidence interval; CRP = C-reactive protein; IGF-1 = Insulin-like growth factor 1; 25(OH)D = 25-hydroxy vitamin D; IL-6 = Interleukin 6.
a,b,c,dTime-dependent variables.
a<0.8 m/s;
b<20 ng/mL;
c≥2.87 pg/mL;
d<112 ng/mL;
eIncluding demographic covariates, diseases, physical activity, daily vitamin D intake (µg; model 1), and body mass index;
fVisit time (reference = baseline visit).